- Published at
- by rttnews.com
positive
positive
Stock Alert: Genfit Gains 25% On Positive Data From Mid-Stage Trial Of Liver Disease Treatment
Shares of Genfit SA (GNFT) are currently gaining nearly 25% after the biopharma company announced positive data from liver disease therapy study. GNFT is currently trading at $6.